Home / Inspections / 1028066

FDA Inspection 1028066 — Hikma Pharmaceuticals USA INC.

Hikma Pharmaceuticals USA INC. — FEI 1510690

The FDA completed an inspection of Hikma Pharmaceuticals USA INC. on September 19, 2017 in Columbus, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 19, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Columbus, OH (United States)

Facility

Other inspections at this facility

  • 1303412 (NAI Thu Apr 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1238509 (NAI Fri Jan 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1243797 (NAI Tue Jul 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1182363 (NAI Thu Sep 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1113855 (NAI Fri Nov 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources